HAHN MARK W (Chief Financial Officer) sold 3.1% of their position (400K shares) of VERONA PHARMA PLC on the open market
Open‑market sale worth $3.73M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 5/29/2025ACC: 0001104659-25-054266
Officer· Chief Financial Officer
Since Jan 2021
-400K
Net shares
Net seller
$3.73M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
400K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
−32.43K
Price / share
$9.53
Trade value
$308.98K
% of position
0.2%
5/27/2025
13.08M→13.05M
Ordinary Shares
Direct
Shares
−162.70K
Price / share
$9.30
Trade value
$1.51M
% of position
1.2%
5/28/2025
13.05M→12.88M
Ordinary Shares
Direct
Shares
−204.86K
Price / share
$9.33
Trade value
$1.91M
% of position
1.6%
5/29/2025
12.88M→12.68M
Total
Net shares
−400K
Net value
-$3.73M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 5/27/2025 | S · Sale | −32.43K | $9.53 | $308.98K | 0.2% | 13.08M | 13.05M |
| Ordinary Shares Direct | 5/28/2025 | S · Sale | −162.70K | $9.30 | $1.51M | 1.2% | 13.05M | 12.88M |
| Ordinary Shares Direct | 5/29/2025 | S · Sale | −204.86K | $9.33 | $1.91M | 1.6% | 12.88M | 12.68M |
| Total | −400K | -$3.73M | ||||||
Derivative Transactions0
No derivative transactions reported